Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data-Reference-Cited by-同舟云学术

Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data

Published:2017-09 Issue:9 Volume:23 Page:958-967
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Brown Joshua D.¹,Shewale Anand R.²,Talbert Jeffery C.³

Affiliation:

1. Institute for Pharmaceutical Outcomes & Policy, Department of Pharmacy Practice & Science, University of Kentucky College of Pharmacy, Lexington, and Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville.

2. Division of Pharmaceutical Evaluation & Policy, University of Arkansas for Medical Sciences, Little Rock.

3. Institute for Pharmaceutical Outcomes & Policy, Department of Pharmacy Practice & Science, University of Kentucky College of Pharmacy, Lexington.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization outcomes of direct oral anticoagulants in Medicare patients;Research in Social and Administrative Pharmacy;2023-11

2. Comprehension of Nonvalvular Atrial Fibrillation and Anticoagulant Adherence in Elderly Patients in a Subcohort Study of the All Nippon Atrial Fibrillation in the Elderly Registry;The American Journal of Cardiology;2023-10

3. Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN‐SPIDERS;British Journal of Clinical Pharmacology;2022-05-22

4. Effectiveness and Safety of Extended Oral Anticoagulant Therapy in Patients with Venous Thromboembolism: A Retrospective Cohort Study;Clinical Pharmacology & Therapeutics;2022-05-02

5. Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation;Scientific Reports;2022-03-01